Multiple Sclerosis Ireland

Lobbying Organisation Multiple Sclerosis Ireland

Date published 15 Sep, 2016

Relevant Matter Matters involving public funds

Public Policy Area Health

Period 1 May, 2016 to 31 Aug, 2016

Specific Details Advocacy work relating to the cannabis-based MS medication Sativex

Intended results Sativex to be reimbursed by the HSE and made available to people with MS.

Name of person primarily responsible for lobbying on this activity Harriet Doig

Did any Designated Public Official(DPO) or former Designated Public Official(DPO) carry out lobbying activities on your behalf in relation to this return? You must include yourself, and answer Yes, if you are a current DPO or a DPO at any time in the past. (What is a Designated Public Official?) No

Did you manage or direct a grassroots campaign? No

Was this lobbying done on behalf of a client? No

Lobbying activity

The following activities occurred for this specific Subject Matter Area.

Email (1)

Email to Catherine Noone requesting meeting or phone call to discuss progressing Sativex and making it available.

Letter (1)

Letter to Minister of Health regarding availability of Sativex

Designated public officials lobbied

The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.

Catherine Noone Senator (Seanad)

Simon Harris Minister (Department of Health)